Utilization and denials of skin and tissue substitutes in Medicare
Elsa Zhang, Yue Gao, Joshua M Liao · 2026
Read Utilization and denials of skin and tissue substitutes in Medicare by Elsa Zhang, Yue Gao, Joshua M Liao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13505515.txt.
Description
Elsa Zhang, Yue Gao, and Joshua Liao traced in 2026 how skin and tissue substitutes are used and denied under Medicare, as a new federal model targets the product class for waste. These graft-like products dress chronic wounds such as diabetic foot ulcers, while their true benefit stays debated. Spending tells its own story.
Outlays climbed from 256 million dollars in 2019 to ten billion in 2024, in the figures cited. Denials climbed too, fed by fears of fraud and loose billing. The piece contrasts Medicare's position with commercial insurers, which lean on prior authorization to hold the line. A 2026 model now applies artificial intelligence in that review. Readers get the policy backdrop for a ten-billion-dollar wound market: the growth, the denials, and the gate just installed.
Catalog record
| CREATOR | Elsa Zhang, Yue Gao, Joshua M Liao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |